CIDRAP
@cidrap.bsky.social
The Center for Infectious Disease Research and Policy at the University of Minnesota
#InfectiousDiseases #PublicHealth #ScienceCommunications
#InfectiousDiseases #PublicHealth #ScienceCommunications
What's Next
The VIP will synthesize decades of safety, effectiveness, and public health data—aiming to give policymakers clear, evidence-based info by early December.
“Any shift that increases the risk of HBV transmission must be grounded in the strongest possible science.” — Dr. Michael Osterholm
The VIP will synthesize decades of safety, effectiveness, and public health data—aiming to give policymakers clear, evidence-based info by early December.
“Any shift that increases the risk of HBV transmission must be grounded in the strongest possible science.” — Dr. Michael Osterholm
November 6, 2025 at 7:50 PM
What's Next
The VIP will synthesize decades of safety, effectiveness, and public health data—aiming to give policymakers clear, evidence-based info by early December.
“Any shift that increases the risk of HBV transmission must be grounded in the strongest possible science.” — Dr. Michael Osterholm
The VIP will synthesize decades of safety, effectiveness, and public health data—aiming to give policymakers clear, evidence-based info by early December.
“Any shift that increases the risk of HBV transmission must be grounded in the strongest possible science.” — Dr. Michael Osterholm
Why It Matters
The birth dose has helped virtually eliminate pediatric hepatitis B in the U.S.—cutting infections by more than 95% since the early 1990s.
Delaying or narrowing that policy could reopen gaps in protection for newborns.
#Vaccines #PublicHealth
The birth dose has helped virtually eliminate pediatric hepatitis B in the U.S.—cutting infections by more than 95% since the early 1990s.
Delaying or narrowing that policy could reopen gaps in protection for newborns.
#Vaccines #PublicHealth
November 6, 2025 at 7:50 PM
Why It Matters
The birth dose has helped virtually eliminate pediatric hepatitis B in the U.S.—cutting infections by more than 95% since the early 1990s.
Delaying or narrowing that policy could reopen gaps in protection for newborns.
#Vaccines #PublicHealth
The birth dose has helped virtually eliminate pediatric hepatitis B in the U.S.—cutting infections by more than 95% since the early 1990s.
Delaying or narrowing that policy could reopen gaps in protection for newborns.
#Vaccines #PublicHealth